Mont. Admin. r. 24.168.911

Current through Register Vol. 23, December 6, 2024

Rule 24.168.911 - OCULAR THERAPEUTIC APPROVED DRUGS

(1) The board hereby approves the following drugs for the use in ocular treatment limited to the anterior segment of the eye and adnexa:

(a) anti-infective agents, including:

(i) antibiotic;

(ii) antiviral;

(iii) antifungal; and

(iv) antiparasitic;

(b) autoimmune agents, including:

(i) antiallergy;

(ii) antihistamines;

(iii) decongestants;

(iv) mast cell stabilizers; and

(v) antianaphylaxis;

(c) analgesics;

(d) anti-inflammatory agents;

(e) antiglaucoma agents;

(f) hyperosmotic agents;

(g) autonomic agents; and

(h) over the counter agents.

Mont. Admin. r. 24.168.911

NEW, 1987 MAR p. 2234, Eff. 12/11/87; AMD, 1990 MAR p. 2176, Eff. 12/14/90; AMD, 1994 MAR p. 153, Eff. 1/28/94; AMD, 1999 MAR p. 2760, Eff. 12/3/99; TRANS, from Commerce, 2003 MAR p. 2083; AMD, 2007 MAR p. 296, Eff. 3/9/07.

37-1-131, 37-10-202, MCA; IMP, 37-10-101, 37-10-103, 37-10-304, MCA;